期刊论文详细信息
Journal of Nanobiotechnology
Delivery of nanovaccine towards lymphoid organs: recent strategies in enhancing cancer immunotherapy
Jing Hu1  Huina Liu2  Ting Cai2  Shun Zhang2  Lingxiao Zhang3 
[1] Key Laboratory of Biomass Chemical Engineering of Ministry of Education, College of Chemical and Biological Engineering, Zhejiang University, 310027, Hangzhou, China;Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, 211200, Hangzhou, China;Ningbo Clinical Research Center for Digestive System Tumors, Ningbo Hwa Mei Hospital, University of Chinese Academy of Sciences, 315010, Ningbo, China;Key Laboratory of Diagnosis and Treatment of Digestive System Tumors of Zhejiang Province, Ningbo Hwa Mei Hospital, University of Chinese Academy of Sciences, 315010, Ningbo, China;Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, 315010, Ningbo, China;Ningbo Clinical Research Center for Digestive System Tumors, Ningbo Hwa Mei Hospital, University of Chinese Academy of Sciences, 315010, Ningbo, China;Key Laboratory of Diagnosis and Treatment of Digestive System Tumors of Zhejiang Province, Ningbo Hwa Mei Hospital, University of Chinese Academy of Sciences, 315010, Ningbo, China;Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, 315010, Ningbo, China;College of Pharmaceutical Sciences, Zhejiang University, 310058, Hangzhou, China;
关键词: Nanovaccine;    Cancer immunotherapy;    Lymphoid organ;    Vaccine delivery;    Immune barrier;   
DOI  :  10.1186/s12951-021-01146-2
来源: Springer
PDF
【 摘 要 】

With the in-depth exploration on cancer therapeutic nanovaccines, increasing evidence shows that the poor delivery of nanovaccines to lymphoid organs has become the culprit limiting the rapid induction of anti-tumor immune response. Unlike the conventional prophylactic vaccines that mainly form a depot at the injection site to gradually trigger durable immune response, the rapid proliferation of tumors requires an efficient delivery of nanovaccines to lymphoid organs for rapid induction of anti-tumor immunity. Optimization of the physicochemical properties of nanovaccine (e.g., size, shape, charge, colloidal stability and surface ligands) is an effective strategy to enhance their accumulation in lymphoid organs, and nanovaccines with dynamic structures are also designed for precise targeted delivery of lymphoid organs or their subregions. The recent progress of these nanovaccine delivery strategies is highlighted in this review, and the challenges and future direction are also discussed.Graphical Abstract

【 授权许可】

CC BY   

【 预 览 】
附件列表
Files Size Format View
RO202112041205576ZK.pdf 5332KB PDF download
  文献评价指标  
  下载次数:26次 浏览次数:7次